Bristol Myers Squibb stock at EUR 57.52, up 1.54%
Published on 11/16/2026 at 08:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness and market focus
- Bristol Myers Squibb operates as a global biopharmaceutical company spanning research, development, production and commercialization.
- Its portfolio covers oncology, hematology, cardiovascular health, immunology, neuroscience and infectious diseases.
Bristol Myers Squibb stock traded at 57.52 euros on Lang & Schwarz at 08:51 CET on Monday, November 16, 2026, 1.54 percent above the Xetra close of Friday, November 13, at EUR 56.65.
Bristol Myers Squibb operates as a global biopharmaceutical company that researches, develops, produces and commercializes medicines across several therapeutic areas.
US equities will be tracked through the S&P 500.
Disclaimer...
en | US1101221083 | BRISTOL MYERS SQUIBB | boerse | 70519902 | bgmi
